2. (1) Generic
(2) No skills or
companies
willingness
wishing
to undertake
to extend their
developments
portolios
(3) Neogen
develops
and licenses out
3. API DEVELOPMENT
PRODUCT SELECTION / FEASABILITY C
2 or
FINISHED DOSE DEVELOPMENT – e Market intel, patent search,
formulation, risk assessment, lab
4 co scale batches, manufacturing
REGISTRATION FILE COMPILATION ye facilities (capacity), commercial
m scale production, stability testing,
ar pe release and controlled transport,
SUBMISSION / REGISTRATION s warehousing, regulatory strategy.
te
nc
SUPPLY / SUPPORT e
SALES AND MARKETING
4. Development and registration
blow fill seal, lyophilized (freeze dried), standard solutions
development (usually) performed inhouse
production outsourced
located in oa. Greece, Germany, France, India and Italy
First mover advantage on several products
First product launched
5. Development and registration
Creams and
Nasal sprays
Entry hurdle: requirement for clinical testing
Performed with external development and production partners
in EU
6. Eric Dubois: 27 years of experience in the pharmaceutical industry
including general management of ratiopharm Belgium and responsible of
dossier development at Docpharma.
Khaled Dandachi: 28 years of experience in technical development of
originator and generic drugs, including for Docpharma, Pfizer, Federa,
Aguettant, Merck-Génériques, Lelin.
Thomas Jacobsen: 12 years of experience in the pharmaceutical
industry, focused on licensing and business development.
7. Esther Kranenburg: 9 years of experience in the pharmaceutical
industry, focused on licensing and business development. Responsible for
licensing for Western Europe and Poland.
Email: esther.kranenburg@neogen.be / Cell: +31 6 2360 1406
Tristram Lake: 9 years of experience in the pharmaceutical industry,
focused on licensing and business development. Responsible for licensing
for CEE (excluding Poland), CIS, Greece, Israel, Italy, Portugal, Russia,
Spain and Turkey.
Email: tristram.lake@neogen.be / Phone: +36 1709 2820 / Cell: +36 302 133 497
www.neogen.be